Search results
Results from the WOW.Com Content Network
Taking a high dose of ADHD drugs is linked to more than five times greater risk of developing psychosis or mania, according to a new study published Thursday in the American Journal of Psychiatry.
Psychosis risk increases 81% on high-dose amphetamine. For this study, researchers analyzed medical data from adults between the ages of 16 and 35 treated at Mass General Brigham between 2005 and ...
Stock image of a hand holding pills. High doses of commonly prescribed medications for ADHD have been linked to an increased risk of psychosis, a new study has found. The “odds of psychosis and ...
Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes [10][13][14][15] and for weight loss. [11][16] Tirzepatide is administered via subcutaneous injections (under the skin). [10][13] It is sold under the brand names Mounjaro for diabetes treatment, [10] and Zepbound for weight loss. [11]
Lisdexamfetamine. Lisdexamfetamine, sold under the brand names Vyvanse and Elvanse among others, is a stimulant medication that is used to treat attention deficit hyperactivity disorder (ADHD) in children and adults and for moderate-to-severe binge eating disorder in adults. [15] Lisdexamfetamine is taken by mouth.
Attention deficit hyperactivity disorder management options are evidence-based practices with established treatment efficacy for ADHD. The American Academy of Pediatrics (AAP) recommends different treatment paradigms depending on the age of the person being treated. For those aged 4–5, the AAP recommends evidence-based parent- and/or teacher ...
Frequency. 0.8–1.5% (2019, using DSM-IV-TR and ICD-10) [ 2 ] Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterised by executive dysfunction occasioning symptoms of inattention, hyperactivity, impulsivity and emotional dysregulation that are excessive and pervasive, impairing in multiple contexts, and ...
The U.S. Drug Enforcement Administration (DEA) has allowed an increase in Vyvanse production of around 24 percent to help with the ADHD drug shortage nationwide. The DEA greenlighted the spike in ...